4236 Organometallics, Vol. 27, No. 16, 2008
Jime´nez et al.
1
tion mixture by H NMR showed the quantitative formation of 1
(C6D6, 298 K): δ 46.09 (s). 13C{1H} NMR (C6D6, 298 K): δ 17.94
(CH2-CR, CH2dCH2), 27.27 (d, JCP ) 3.0, PCCH3), 27.79 (d, JCP
1
and 2-methoxypropene: H NMR (acetone-d6, 298 K): δ 3.85 (s,
2H, dCH2), 3.52 (s, 3H, OCH3), 1.82 (s, 3H, CH3). GC-MS
) 3.8, PCCH3), 27.91 (d, JCP ) 28.6, PCCH3), 32.24 (d, JCP )
(CD2Cl2): m/z 72 [M]+.
27.5, PCCH3), 52.34 (OCH3), 62.03 (CH2-Cꢀ), 111.74, 113.26,
118.23 (CH-PhO), not seen (C1). Anal. Calcd (%) for C19H34IrO2P
(517.6715): C 44.08, H 6.62. Found: C 43.78, H 5.98.
Preparation of [IrH2{η5-3-(pz)-C6H5O(CH2)2Pt-Bu2-k-P}]
(10). A solution of [IrH2(η6-C6H5O(CH2)2Pt-Bu2-k-P)][BF4] (3)
(40 mg, 0.073 mmol) in acetone-d6 (0.5 mL) was treated with
Reaction of [Ir{η5-3-(CH3COCH2)C6H5O(CH2)2Pt-Bu2-k-
P}(C2H4)] (4) with Triflic Acid. Compound 4 (0.027 mmol) was
reacted with HCF3SO3 in CD2Cl2 and the reaction monitored by
1
NMR. Analysis of the solution mixture by H NMR and GC-MS
showed the formation of 1 and acetone.
Preparation of [Ir(η5-C6H5O)(C2H4)(t-Bu2PCHdCH2)] (7).
Method A: A suspension of 4 (100 mg, 0.18 mmol) in methanol
(10 mL) was stirred for 8 h, the solvent was evacuated, and the
residue was treated with pentane, washed with pentane, and dried
in vacuo. Yield: 64 mg (72%). Method B: A solution of 1 (200
mg, 0.35 mmol) in acetone (10 mL) was treated with potassium
hydroxide in methanol (1 mmol). After 2 h of stirring, the solvent
was pumped off and the residue treated with diethyl ether. The
resulting brown solution was filtered, concentrated to ca. 0.5 mL,
and treated with pentane. A light yellow solid precipitated, which
was filtered, washed twice with 2 mL portions of pentane, and dried
in vacuo. Yield: 64 mg (38%). IR (Nujol mull, cm-1): 1625 (m)
ν(CdO), 1540 (m) ν(CdC). 1H NMR (acetone-d6, 298 K): δ 1.30
(d, JHP ) 13.3, 18H, PCCH3), 1.41 (m, 2H, endo-H CH2dCH2),
2.16 (m, 2H, exo-H CH2dCH2), 4.95 (d, JHH ) 6.7, 2H, H2), 5.75
(t, JHH ) 5.4, 1H, H4), 5.82 (dd, JHP ) 12.0, JHH ) 4.0, 1H, dCH2),
potassium pyrazolate (7.7 mg, 0.073 mmol) at -78 °C and then
13
allowed to warm up to -60 °C. 1H and
C{1H} NMR
evidenced the formation of compound 10. Spectroscopic data:
1H NMR (acetone-d6, 213 K): -17.10 (dd, JHP ) 18.9, JHH
)
7.4, 1H, Ir-H), -11.25 (dd, JHP ) 21.4, JHH ) 7.4, 1H, Ir-H),
1.13 (d, JHP ) 13.3, 9H, PCCH3), 1.26 (d, JHP ) 12.6, 9H,
PCCH3), 1.46 (m, 2H, CH2-CR), 3.69 (m, 1H, H4), 3.87 (d, JHH
) 6.2, 1H, H3), 4.10 (m 1H, CH2-Cꢀ), 4.24 (m, 1H, CH2-Cꢀ),
5.20 (dd, JHH ) 5.6, 5.6, 1H, H2), 5.31 (m, 1H, H6), 6.14 (m,
1H, Pz-H4), 6.15 (m, 1H, H5), 7.34 (d, JHH ) 1.0, 1H, Pz-H5),
7.40 (d, JHH ) 1.0, 1H, Pz-H3). 31P{1H} NMR (acetone-d6, 213
K): δ 39.27 (s). 13C{1H} NMR (acetone-d6, 213 K): δ 13.01 (d,
JCP ) 26.3, CH2-CR), 28.60 (PCCH3), 29.48 (d, JCP ) 4.5,
PCCH3), 34.56 (d, JCP ) 26.8, PCCH3), 35.47 (d, JCP ) 28.5,
PCCH3), 35.67 (d, JCP ) 28.3, C4), 41.98 (C3), 60.62 (d, JCP
)
3.8 Hz, C2), 69.07 (C5), 69.79 (CH2-Cꢀ), 90.87 (C6), 104.84,
126.31 (CH-Pz), 130.49 (C1), 137.99 (CH-Pz).
5.83 (dd, JHP ) 10.9, JHH ) 11.3, 1H, dCH2), 6.08 (ddd, JHP
)
X-ray Structural Determination of Compounds 4 and 7.
Crystals of complex 4 suitable for the X-ray diffraction
experiment were obtained by slow evaporation of diethyl ether
from a concentrated solution at room temperature in the drybox.
Suitable crystals of 7 were obtained by slow diffusion of diethyl
ether into a concentrated solution of the compound in acetone
at 0 °C. Both sets of intensity data were collected at low
temperature (100(2) K) on a CCD Bruker SMART APEX
diffractometer with graphite-monochromated Mo KR radiation
(λ ) 0.71073 Å) by using ω rotations (0.3°). Instrument and
crystal stability were evaluated by measuring equivalent reflec-
tions at different times; no significant decay was observed. Data
were corrected for Lorentz and polarization effects, and a
semiempirical absorption correction was applied.41 The structure
was solved by Patterson and difference Fourier methods.42
Anisotropic displacement parameters were applied for all non-
hydrogen atoms. Hydrogen atoms were found in subsequent
difference Fourier maps and included as free isotropic atoms.
Refinements were carried out by full-matrix least-squares on F2
(SHELXL-97).41 The highest residuals in both structures were
found in the proximity of metal centers and have no chemical
sense.
Crystal data for compound 4: C21H36IrO2P, M ) 543.67; crystal
size 0.252 × 0.247 × 0.041 mm3; monoclinic, P21/n; a )
13.1600(8) Å, b ) 8.4206(5) Å, c ) 19.5860(12) Å; ꢀ )
105.4520(10)°; Z ) 4; V ) 2092.0(2) Å3; Dc ) 1.726 g/cm3; µ )
6.470 mm-1, minimum and maximum transmission factors 0.262
and 0.775; 2θmax ) 55.4°; 13 531 reflections collected, 4946 unique
[R(int) ) 0.0339]; number of data/restrains/parameters 4946/0/370;
final GoF 1.048, R1 ) 0.0301 [4427 reflns I > 2σ(I)], wR2 ) 0.0706
for all data.
30.8, JHH ) 11.3, JHH ) 4.0, 1H, dCH), 6.20 (dd, JHH ) 6.7, 5.4,
2H, H3). 31P{1H} NMR (acetone-d6, 298 K): δ 32.02 (s). 13C{1H}
NMR (acetone-d6, 298 K): δ 17.94 (br, CH2dCH2), 30.27 (d, JCP
) 3.6, PCCH3), 37.93 (d, JCP ) 26.5, PCCH3), 80.10 (C2), 81.15
(C4), 97.37 (C3), 124.65 (d, JCP ) 39.8, PCHdCH2), 130.03
(PCHdCH2), 166.43(CO C1). Anal. Calcd (%) for C18H30IrOP
(485.6294): C 44.52, H 6.23. Found: C 44.58, H 6.29.
Preparation of [Ir(η5-C6H5O)(C3H6)(t-Bu2PCHdCH2)] (8).
Method A: The compound was prepared from [Ir{η5-3-
(CH3COCH2)C6H5O(CH2)2Pt-Bu2-k-P}(C3H6)] (5) following the
procedure described for compound 7 and isolated as a pale
yellow solid. Yield: 76 mg (45%). IR (Nujol mull, cm-1): 1630
1
(m) ν(CdO), 1545 (m) ν(CdC). H NMR (acetone-d6, 298 K):
δ 1.29 (d, JHP ) 13.2, 9H, PCCH3), 1.32 (d, JHP ) 13.2, 9H,
PCCH3), 1.56 (d, JHP ) 6.0, 9H, dCHCH3), 1.59 (dd, JHH
)
13.2, 1.5, 1H, dCH2), 1.90 (ddd, JHH ) 9.6, JHH ) JHP ) 1.5,
1H, dCH2), 2.10 (m, 1H, dCHCH3), 4.71 (d, JHH ) 6.9, 1H,
H2 or H6), 5.35 (d, JHH ) 6.9, 1H, H2 or H6), 5.74 (t, JHH ) 5.7,
1H, H4), 5.83 (dd, JHP ) 12.0, JHH ) 2.7, 1H, dCH2), 5.86 (dd,
JHP ) 14.1, JHH ) 11.4, 1H, dCH2), 6.07 (dd, JHH ) 6.9, 5.7,
1H, H3 or H5), 6.11 (ddd, JHP ) 33.0, JHH ) 11.4, JHH ) 2.7,
1H, dCH), 6.18 (dd, JHH ) 6.9, 5.7, 1H, H3 or H5). 31P{1H}
NMR (C6D6, 298 K): δ 31.43 (s). 13C{1H} NMR (C6D6, 298
K): δ 14.23 (dCH CH3), 21.64 (dCH2), 22.68 (dCHCH3), 29.78
(d, JCP ) 4.0, PCCH3), 30.39 (PCCH3), 37.61 (d, JCP ) 27.1,
PCCH3), 38.15 (d, JCP ) 26.3, PCCH3), 77.53 (C2), 83.45 (C4),
98.02 (C3), 124.00 (d, JCP ) 35.8, PCHdCH2), 129.19
(PCHdCH2), 166.19 (s, CO, C1). Anal. Calcd (%) for C19H32IrOP
(499.6562): C 45.67, H 6.45. Found: C 45.58, H 6.36.
Preparation of [Ir(OC6H5)(C2H4)(t-Bu2P(CH2)2OMe-k2-O,P)]
(9). A solution of 7 (100 mg, 0.21 mmol) in toluene (5 mL) was
treated with methanol (20 µL, 0.49 mmol). After 2 h of stirring,
the solvent was pumped off and the residue treated with hexane at
0 °C. The resulting brown solid was washed with hexane, filtered,
and dried in vacuo. Yield: 66 mg (61%). IR (Nujol mull, cm-1):
1060 (m) ν(CsO), 1580 (m) ν(CdC). 1H NMR (C6D6, 298 K): δ
1.10 (d, JHP ) 13.2, 18H, PCCH3), 1.51 (dt, JHP ) 6.1, JHH ) 6.1,
2H, CH2-CR), 1.60 (m, 2H, endo-H CH2dCH2), 2.05 (m, 2H,
Crystal data for compound 7: C18H30IrOP · C6H6O, M )
579.72; crystal size 0.299 × 0.247 × 0.089 mm3; monoclinic, P21/
n; a ) 7.9252(6) Å, b ) 29.893(2) Å, c ) 9.7153(7) Å; ꢀ )
102.441(1)°; Z ) 4; V ) 2247.6(3) Å3; Dc ) 1.713 g/cm3; µ )
(41) SAINT+ Software for CCD difractometers; Bruker AXS: Madison,
WI, 2000. (b) Sheldrick, G. M. SADABS Program for Correction of Area
Detector Data V. 2.03; University of Go¨ttingen: Go¨ttingen, Germany, 2001.
(42) SHELXTL Package V. 6.10; Bruker AXS: Madison, WI, 2000.
Sheldrick G. M. SHELXS-86 and SHELXL-97; University of Go¨ttingen:
Go¨ttingen, Germany, 1997.
exo-H CH2dCH2), 3.07 (s, 3H, MeO), 3.24 (dt, JHP ) 12.0, JHH
6.1, 2H, CH2-Cꢀ), 6.89 (t, JHH ) 7.7, 1H, PhO), 7.04 (dd, JHH
)
)
7.7, 7.6, 2H, PhO), 7.20 (d, JHH ) 7.6, 1H, PhO). 31P{1H} NMR